AtriCure
ATRC
ATRC
107 hedge funds and large institutions have $683M invested in AtriCure in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
4.82% less ownership
Funds ownership: 87.81% → 82.99% (-4.8%)
25% less call options, than puts
Call options by funds: $313K | Put options by funds: $420K
Holders
107
Holding in Top 10
5
Calls
$313K
Puts
$420K
Top Buyers
| 1 | +$6.26M | |
| 2 | +$3.33M | |
| 3 | +$2.87M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.77M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.32M |
Top Sellers
| 1 | -$31M | |
| 2 | -$2.98M | |
| 3 | -$2.76M | |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$2.46M |
| 5 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$2.39M |